Background: There are no previous Spanish guidelines or consensus statements on bradykinin-induced angioedema.
Aim: To draft a consensus statement on the management and treatment of angioedema mediated by bradykinin in light of currently available scientific evidence and the experience of experts. This statement will serve as a guideline to health professionals.
Methods: The consensus was led by the Spanish Study Group on Bradykinin-Induced Angioedema, a working group of the Spanish Society of Allergology and Clinical Immunology. A review was conducted of scientific papers on different types of bradykinin-induced angioedema (hereditary and acquired angioedema due to C1 inhibitor deficiency, hereditary angioedema related to estrogens, angioedema induced by angiotensin-converting enzyme inhibitors). Several discussion meetings were held to reach the consensus.
Results: Treatment approaches are discussed, and the consensus reached is described. Specific situations are addressed, namely, pregnancy, contraception, travelling, blood donation, and organ transplantation.
Conclusions: A review of and consensus on treatment of bradykinin-induced angioedema is presented.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Angioedema.
Allergy Asthma Clin Immunol
December 2024
Division of Allergy and Immunology, Department of Medicine, Western University, London, ON, Canada.
Angioedema can occur in the absence of urticaria and can be broadly divided into three main categories: mast cell-mediated (e.g., histamine), non-mast-cell-mediated (bradykinin-induced) and idiopathic angioedema.
View Article and Find Full Text PDFAngioedema is a condition characterized by non-pitting swelling of the subcutaneous or submucosal tissues in particular the face, lips, and oral cavity. Angiotensin-converting enzyme (ACE) inhibitors are known to contribute to the development of angioedema by increasing the levels of bradykinin and its active metabolites. Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is hypothesized to contribute to the development of angioedema by modifying ACE II levels and further increasing the level of bradykinin in patients taking ACE inhibitors.
View Article and Find Full Text PDFMast cell degranulation and bradykinin-induced angioedema - searching for the missing link.
Front Immunol
May 2024
Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
Article Synopsis
- Initiation of the bradykinin cascade can cause angioedema attacks without wheals, particularly in hereditary angioedema due to C1 inhibitor deficiency (HAE-C1-INH), highlighting a complex interplay between mast cells and this process.
- * Recent findings suggest mast cell degranulation might activate the kallikrein-kinin system, leading to bradykinin formation, while also revealing a connection between bradykinin and histamine symptoms, despite their distinct clinical presentations.
- * Exploring mast cell-related receptors, specifically MRGPRX2, and their ligands could help understand individual variability in HAE-C1-INH responses, raising important questions about potential therapeutic interventions targeting mast cell activation versus br
Pseudo-Allergies in the Emergency Department: A Common Misdiagnosis of Hypersensitivity Type 1 Allergic Reaction.
Cureus
October 2023
Emergency Medicine, Freeman Health System, Joplin, USA.
Type-1 hypersensitivity reaction represents an acute IgE-mediated reaction that can cause life-threatening conditions, such as anaphylactic shock, angioedema, and airway obstruction. Other reactions that can mimic type-1 hypersensitivity reactions include IgE-independent mast cell degranulation, bradykinin-mediated reactions, leukotrienes-mediated reactions, and pseudo-allergies. We use the term pseudo-allergy in this article for histamine-mediated reactions that are mast cell-independent.
View Article and Find Full Text PDFRemember bradykinin-induced angioedema - an unforgettable image.
An Pediatr (Engl Ed)
June 2023
Servicio de Inmunología y Alergia, Centro Hospitalar e Universitário de São João, Oporto, Portugal; Departamento de Obstetricia y Ginecología, Faculdad de Medicina, Universidade do Porto, Oporto, Portugal.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!